ロード中...
Influenza treatment with neuraminidase inhibitors: Cost-effectiveness and cost-utility in healthy adults in the United Kingdom
We assessed the cost-effectiveness and cost-utility of treating influenza with neuraminidase inhibitors (oseltamivir and zanamivir) from a health care payer’s and societal perspective in the United Kingdom. A simulation model was developed to predict morbidity and mortality due to influenza and its...
保存先:
| 出版年: | Eur J Health Econ |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087894/ https://ncbi.nlm.nih.gov/pubmed/15875227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10198-005-0297-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|